Home/Filings/4/0001415889-23-003932
4//SEC Filing

Lloyd Brian G. 4

Accession 0001415889-23-003932

CIK 0000856982other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 8:22 PM ET

Size

16.2 KB

Accession

0001415889-23-003932

Insider Transaction Report

Form 4
Period: 2023-02-28
Lloyd Brian G.
CHIEF LEGAL OFFICER, SECRETARY
Transactions
  • Tax Payment

    Common Stock, No Par Value

    2023-02-28$70.58/sh3,107$219,29217,370 total
  • Award

    Common Stock, No Par Value

    2023-02-28+10,18320,477 total
  • Award

    Non-qualified stock options (right to buy)

    2023-02-28+13,57613,576 total
    Exercise: $70.58From: 2024-02-28Exp: 2030-02-28Common Stock (13,576 underlying)
Holdings
  • Non-qualified stock options (right to buy)

    Exercise: $55.73From: 2020-03-01Exp: 2026-03-01Common Stock (30,000 underlying)
    30,000
  • Non-qualified stock options (right to buy)

    Exercise: $56.25From: 2022-03-19Exp: 2028-03-19Common Stock (9,681 underlying)
    9,681
  • Non-qualified stock options (right to buy)

    Exercise: $44.80From: 2019-03-02Exp: 2025-03-02Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $37.71From: 2021-02-26Exp: 2027-02-26Common Stock (16,722 underlying)
    16,722
  • Non-qualified stock options (right to buy)

    Exercise: $65.03From: 2023-02-28Exp: 2029-02-28Common Stock (8,094 underlying)
    8,094
Footnotes (8)
  • [F1]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.26.2020 and 03.19.2021.
  • [F2]These shares were not sold in an open-market transaction.
  • [F3]Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
  • [F4]Become exercisable in equal annual installments of 20% commencing on 03/02/2019.
  • [F5]Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
  • [F6]Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
  • [F7]Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
  • [F8]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001671772

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:22 PM ET
Size
16.2 KB